Top Suppliers:I want be here

2763730-97-6

2763730-97-6 structure
2763730-97-6 structure
  • Name: SLF1081851
  • Chemical Name: SLF1081851
  • CAS Number: 2763730-97-6
  • Molecular Formula: C21H33N3O
  • Molecular Weight: 343.51
  • Catalog: Signaling Pathways GPCR/G Protein LPL Receptor
  • Create Date: 2022-08-04 12:58:31
  • Modify Date: 2025-08-26 15:09:55
  • SLF1081851 (16 d) is an effective Sphingolipid Transporter 2 (Spns2) (S1P transporter) inhibitor with an IC50 value of 1.93 μM (S1P), SLF1081851 inhibits SphK2 with an IC50 value of ≈ 30 μM (SphK2), and is at least 15-fold more selective for SphK2 than SphK1. SLF1081851 has the potential to investigate Spns2 biology and can be used for autoimmune encephalomyelitis (EAE) research[1].

Name SLF1081851
Description SLF1081851 (16 d) is an effective Sphingolipid Transporter 2 (Spns2) (S1P transporter) inhibitor with an IC50 value of 1.93 μM (S1P), SLF1081851 inhibits SphK2 with an IC50 value of ≈ 30 μM (SphK2), and is at least 15-fold more selective for SphK2 than SphK1. SLF1081851 has the potential to investigate Spns2 biology and can be used for autoimmune encephalomyelitis (EAE) research[1].
Related Catalog
Target

IC50: 1.93 μM (SIP), ≈ 30 μM (SphK2)[1].

In Vivo SLF1081851 (C57BL/6j strain mice or Sprague-Dawley strain rats; 10 or20 mg/kg; i.p., 4 h postdose) significantly inhibits circulating lymphocytes and plasma S1P, recapitulates the genetic phenotype of Spns2 null mice[1]. Animal Model: Mice (C57BL/6j strain), rats (Sprague-Dawley strain)[1]. Dosage: 10, 20 mg/kg. Administration: I.p., blood was drawn 4 h postdose. Result: Inhibited circulating lymphocytes and plasma S1P [1]. Animal Model: 4 week old male rats[1]. Dosage: 10 mg/kg. Administration: I.p. (Pharmacokinetic Analysis). Result: Reached a maximum concentration of 5 μM in blood at 2 h with drug levels sustained at ≥ 2 μM for at least 24 h, proved a half-life of over 8 h in rats. The appearance of SPNS2-IN-1 in circulation correlated with a maximal decrease in lymphocyte count at 4 h (25% lower compared to time = 0).
References

[1]. Russell Fritzemeier, et al. Discovery of In Vivo Active Sphingosine-1-phosphate Transporter (Spns2) Inhibitors. J Med Chem. 2022 Jun 9;65(11):7656-7681

Molecular Formula C21H33N3O
Molecular Weight 343.51
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.